The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function

Nephron - Clinical Practice

Volumn 118, Issue 3, 2011, Pages

  Koivuviita, N ^a   Tertti, R ^a   Luotolahti, M ^a   Raitakari, O ^b   Vahlberg, T ^c   Nuutila, P ^a   Knuuti, J ^c   Metsarinne K ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Atherosclerotic renovascular disease; Coronary flow reserve; Myocardial blood flow; Positron emission tomography; Renal artery stenosis

Indexed keywords

DIPYRIDAMOLE;

AGED; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY FLOW RESERVE; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE MASS; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; HYPEREMIA; HYPERTENSION; KIDNEY ARTERY STENOSIS; MALE; NEPHROSCLEROSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ATHEROSCLEROSIS; BLOOD PRESSURE; BRACHIAL ARTERY; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NATRIURETIC PEPTIDE, BRAIN; POSITRON-EMISSION TOMOGRAPHY; RENAL ARTERY OBSTRUCTION;

EID: 78650663652     PISSN: 16602110     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000321643     Document Type: Article

References (42)

1. Safian R, Textor S: Renal-artery stenosis. N Engl J Med 2001; 344: 431-442. (Pubitemid 32128677)
2. Hansen K, Edwards M, Craven T, Cherr G, Jackson S, Appel R, Burke G, Dean R: Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg 2002; 36: 443-451.
3. Olin J, Melia M, Young J, Graor R, Risius B: Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990; 88: 46N-51N. (Pubitemid 20055403)
4. MacDowall P, Kalra P, O'Donoghue D, Waldek S, Mamtora H, Brown K: Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998; 352: 13-16. (Pubitemid 28306559)
5. ASTRAL investigators, Wheatley, K, Ives N, Gray P, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J: Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361: 1953-1962.
6. Kalra P, Guo H, Kausz A, Gilbertson D, Liu J, Chen S, Ishani A, Collins A, Foley R: Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk factors, revascularization, and prognosis. Kidney Int 2005; 68: 293-301. (Pubitemid 43181388)
7. Wright J, Shurrab A, Cooper A, Kalra P, Foley R, Kalra P: Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol 2005; 16: 2746-2753.
8. Antony I, Nitenberg A, Foult J, Aptecar E: Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993; 22: 514-520. (Pubitemid 23214566)
9. Treasure C, Klein J, Vita J, Manoukian S, Renwick G, Selwyn A, Ganz P, Alexander R: Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93. (Pubitemid 23019338)
10. Wright J, Shurrab A, Cooper A, Kalra P, Foley R, Kalra P: Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM 2009; 102: 695-704.
11. Zeller T, Rastan A, Schwarzwälder U, Müller C, Frank U, Bürgelin K, Sixt S, Schwarz T, Noory E, Neumann F: Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther 2007; 14: 189-197. (Pubitemid 46776117)
12. Symonides B, Chodakowska J, Januszewicz A, Lapinski M, Januszewicz M, Rowinski O, Szmidt J, Kuch-Wocial A, Kurzyna M, Malek G, Berent H, Szmigielski C, Januszewicz W: Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology. Blood Press 1999; 8: 141-150.
13. Corriere M, Hoyle J, Craven T, D'Agostino RJ, Edwards M, Moore P, Hansen K: Changes in left ventricular structure and function following renal artery revascularization. Ann Vasc Surg 2010; 24: 80-84.
14. Taddei S, Virdis A, Mattei P, Salvetti A: Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-933. (Pubitemid 23166942)
15. Leipert B, Becker B, Gerlach E: Different endothelial mechanisms involved in coronary responses to known vasodilators. Am J Physiol 1992; 262:H1676-H1683.
16. Buus N, Bøttcher M, Hermansen F, Sander M, Nielsen T, Mulvany M: Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 2001; 104: 2305-2310. (Pubitemid 33049513)
17. Pitkänen O, Raitakari O, Niinikoski H, Nuutila P, Iida H, Voipio-Pulkki L, Härkönen R, Wegelius U, Rönnemaa T, Viikari J, Knuuti J: Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996; 28: 1705-1711. (Pubitemid 26426223)
18. Nesterov S, Han C, Mäki M, Kajander S, Naum A, Helenius H, Lisinen I, Ukkonen H, Pietilä M, Joutsiniemi E, Knuuti J: Myocardial perfusion quantitation with 15 O-labelled water PET: High reproducibility of the new cardiac analysis software (Carimas). Eur J Nucl Med Mol Imaging 2009; 36: 1594-1602.
19. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma A: Myocardial blood flow: Comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 1995; 36: 78-85.
20. Koivuviita N, Tertti R, Järvisalo M, Pietilä M, Hannukainen J, Sundell J, Nuutila P, Knuuti J, Metsärinne K: Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease. Nephrol Dial Transplant 2009; 24: 2773-2779.
21. Järvisalo M, Rönnemaa T, Volanen I, Kaitosaari T, Kallio K, Hartiala J, Irjala K, Viikari J, Simell O, Raitakari O: Brachial artery dilatation responses in healthy children and adolescents. Am J Physiol Heart Circ Physiol 2002; 282:H87-H92. (Pubitemid 34654138)
22. Sahn D, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083. (Pubitemid 9091990)
23. Devereux R, Alonso D, Lutas E, Gottlieb G, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458. (Pubitemid 16119719)
24. Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Am erican Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
25. Bergmann S, Herrero P, Markham J, Weinheimer C, Walsh M: Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989; 14: 639-652. (Pubitemid 19229339)
26. Czernin J, Müller P, Chan S, Brunken R, Porenta G, Krivokapich J, Chen K, Chan A, Phelps M, Schelbert H: Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993; 88: 62-69. (Pubitemid 23195433)
27. Kaufmann P, Camici P: Myocardial blood flow measurement by PET: Technical aspects and clinical applications. J Nucl Med 2005; 46: 75-88. (Pubitemid 43086001)
28. Parodi O, Neglia D, Palombo C, Sambuceti G, Giorgetti A, Marabotti C, Gallopin M, Simonetti I, L'Abbate A: Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. Circulation 1997; 96: 864-873. (Pubitemid 27329621)
29. Akinboboye O, Chou R, Bergmann S: Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: A comparison of lisinopril and losartan. J Am Coll Cardiol 2002; 40: 703-709. (Pubitemid 34925617)
30. Motz W, Strauer B: Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996; 27: 1031-1038. (Pubitemid 26140657)
31. Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H: Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 2007; 50: 1144-1149. (Pubitemid 47375012)
32. Uren N, Melin J, De Bruyne B, Wijns W, Baudhuin T, Camici P: Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994; 330: 1782-1788.
33. Mistry S, Ives N, Harding J, Fitzpatrick-Ellis K, Lipkin G, Kalra P, Moss J, Wheatley K: Angioplasty and stent for renal artery lesions (Astral trial): Rationale, methods and results so far. J Hum Hypertens 2007; 21: 511-515. (Pubitemid 47018623)
34. Silva J, Chan A, White C, Collins T, Jenkins J, Reilly J, Ramee S: Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005; 111: 328-333. (Pubitemid 40165340)
35. Endemann D, Schiffrin E: Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992. (Pubitemid 39031337)
36. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678. (Pubitemid 33108132)
37. Landmesser U, Hornig B, Drexler H: Endothelial function: A critical determinant in atherosclerosis? Circulation 2004; 109:II27-II33.
38. Yilmaz M, Saglam M, Carrero J, Qureshi A, Caglar K, Eyileten T, Sonmez A, Cakir E, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J: Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 959-965. (Pubitemid 351767576)
39. Meyer M, Lieps D, Schatz H, Pfohl M: Impaired flow-mediated vasodilation in type 2 diabetes: Lack of relation to microvascular dysfunction. Microvasc Res 2008; 76: 61-65.
40. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K: Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346: 1954-1962. (Pubitemid 34651355)
41. Panza J, Quyyumi A, Brush JJ, Epstein S: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27. (Pubitemid 20209468)
42. Järvisalo M, Jartti L, Marniemi J, Rönnemaa T, Viikari J, Lehtimäki T, Raitakari O: Determinants of short-term variation in arterial flow-mediated dilatation in healthy young men. Clin Sci (Lond) 2006; 110: 475-482.